Im Cannabis Corp. · NASDAQ:IMCC
Im Cannabis — Investor Presentation (May 2020)
17 slides from Im Cannabis's investor presentation, May 2020
Slide 1: Leveraging Israeli Cannabis Expertise for Global Expansion
CSE:IMCC IM Cannabis Corp. LEVERAGING ISRAELI CANNABIS EXPERTISE FOR GLOBAL EXPANSION Q2 2020
Slide 2: Disclaimer
Disclaimer General The information found herein, and any other materials provided by IM Cannabis Corp.(“IMC” or the “Company”), are intended solely for discussion purposes and are not intended as, and do not constitute, an offer to sell or a solicitation of an offer to buy any security, and should n
Slide 3: Disclaimer
Disclaimer United States Securities Laws This investor presentation is not a prospectus or an offering memorandum pursuant to applicable US securities laws. The securities of IMC have not been and will not be registered under the United States federal or state securities laws and may not be offered
Slide 4: IMC – Investment Highlights
IMC – Investment Highlights Proven Israeli Operator $193.5 million in binding sales agreements for next 3 years by Focus Medical* 10 years experience Distribution in largest pharmacy group Export optionality on the horizon Established EU Platform €7.7 billion total value of German medical cannabis m
Slide 5: IMC at a Glance
IMC at a Glance Summary of Assets Supply Chain Flow Israel Leadership Exclusive commercial agreement with licensed Distribution Distribution position in Israel producer, Focus Medical Herbs Ltd., for IMC’s IP and branding (export) to Germany (export) to EU $193.5 million in consolidated revenue over
Slide 6: IMC - Expansion Strategy Implementation
IMC - Expansion Strategy Implementation Focus Spanish Partner - 18,000kg of production capacity in 2020 Intelicana Way of Life Cannomed Cannation Total Production Capacity of 28,700kg Total Production Capacity of 46,700kg 2020-2023 with NO Extra CAPEX by the end of 2022 with no extra CAPEX Operating
Slide 7: IMC Branded Products
IMC Branded Products Inflorescences Extracts 7
Slide 8: Highlights of IMC’s Israeli Operations
Highlights of IMC’s Israeli Operations Established Operations in Israel Focus Medical Herbs Ltd. is licensed to cultivate, produce and sell cannabis and cannabis oil for medical purposes. Focus commenced operations in 2010 IMC holds a license agreement and a commercial agreement with Focus for IMC’s
Slide 9: IMC’s German Strategy
IMC’s German Strategy The Goal: Market Leadership Over 1 million patients IMC’s goal is to be the market leader. Physicians become more comfortable prescribing a brand that is widespread therefore it is vital that IMC gain brand forecast by 2024 recognition before other players enter the market € 7.
Slide 10: IMC Germany - Adjupharm Positioned for Market Leadership
IMC Germany - Adjupharm Positioned for Market Leadership Sales B2B Sales B2C ✓ Binding sales agreements with 3 ✓ Reaching over 6,000 pharmacies distributors ✓ Sales of Bedrocan since December ✓ EU-sourced EU-GMP supply expected 2019 Q2 2020 ✓ Robust patient-centered marketing ✓ Expected gross margin
Slide 11: IMC Germany - Adjupharm Positioned for Market Leadership
IMC Germany - Adjupharm Positioned for Market Leadership Facility Licenses & Permits Winning Team ✓ Storage space in construction for ✓ Licensed to import over ✓ Decades of accumulated over 5,000kg of cannabis 4,000Kg of medical pharmaceutical ✓ Off the shelf supply availability cannabis flower and
Slide 12: IMC - Company Milestones and Capital Raised
IMC - Company Milestones and Capital Raised Focus Medical receives the IMC-GAP from Israeli regulatory Focus Medical signs 3 years sales agency enabling IMC to export and agreements valued at $15M to serve patients IMC Holdings under new reform Focus Medical increases production IMC Holdings capabil
Slide 13: IMC Leadership Team
IMC Leadership Team Oren Shuster Shai Shemesh, CPA Yaron Berger Richard Balla Chief Executive Officer & Director Chief Financial Officer Managing Director Israel Operation CEO and Director Adjupharm GmbH ▪ Co-founder of IMC and leading figure ▪ Experienced CFO with nearly 15 years ▪ Experienced entr
Slide 14: IMC Board Members
IMC Board Members Oren Shuster Marc Lustig Steve Mintz, CPA Rafi Gabay Vivian Bercovici Chief Executive Officer & Director Chairman Director Director Director ▪ Co-founder of IMC and leading ▪ Founder and CEO of ▪ Financial consultant in a ▪ Mr. Gabay is Chairman and ▪ Former Canada's figure in Isra
Slide 15: IMC – COVID-19 Update
IMC – COVID-19 Update Focus Medical declared essential service by Israeli government, no interruption in cultivation activities Spanish supply partner continues to cultivate without interruption Operations update: Complete transition to work from home Reduction in discretionary operational expenses
Slide 16: IMC: Facts and Figures
IMC: Facts and Figures Financially Sound Leadership Position Capacity and Expansion $9.1 million $193.5 million 46,700 KG 2019 revenue 1 Consolidated revenue over next 3 Supply from Israeli and years from sales agreements signed 75% YOY growth by Focus Medical in Israel European partners in 2020-202
Slide 17: Thank you
CSE:IMCC IM Cannabis Corp. Thank you